# Idiopathic Intracranial Hypertension Treatment Trial

> **NCT01003639** · PHASE2,PHASE3 · COMPLETED · sponsor: **St. Luke's-Roosevelt Hospital Center** · enrollment: 165 (actual)

## Conditions studied

- Idiopathic Intracranial Hypertension

## Interventions

- **DRUG:** Acetazolamide
- **DRUG:** Placebo
- **BEHAVIORAL:** Formal weight loss counselling program

## Key facts

- **NCT ID:** NCT01003639
- **Lead sponsor:** St. Luke's-Roosevelt Hospital Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2013-06
- **Final completion:** 2014-01
- **Target enrollment:** 165 (ACTUAL)
- **Last updated:** 2018-12-12

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01003639

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01003639, "Idiopathic Intracranial Hypertension Treatment Trial". Retrieved via AI Analytics 2026-09-20 from https://api.ai-analytics.org/clinical/NCT01003639. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*